Expression Genetics

Expression Genetics is a privately held biopharmaceutical company specializing in nucleic acid delivery and therapeutics targeting specific disease targets. The company is dedicated to developing treatments for human diseases. It holds significant intellectual property positions in biocompatible polymers, its novel nucleic acid compositions, and their therapeutic applications. EGEN's research pipeline products are aimed at treating various cancers and cardiovascular diseases involving siRNA, shRNA, tumor antigens, and angiogenic genes. EGEN has collaborated with external investigators, biotechnology organizations, and universities on various projects in these areas.